Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018

Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018

Bibliographic Details
Main Authors: Ashleigh McGirr, Shehzad M. Iqbal, Jan Olbrecht, Lijoy Varghese
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-11-01
Series:Infectious Diseases and Therapy
Subjects:
Canada
Cost-effectiveness
Invasive pneumococcal disease
PCV-13
PHiD-CV
Pneumococcal conjugate vaccines
Online Access:http://link.springer.com/article/10.1007/s40121-018-0220-3

Internet

http://link.springer.com/article/10.1007/s40121-018-0220-3

Similar Items